The synthetics biology company CB Therapeutics recently named Tiffany Hurd as its new business development lead. At Carlsbad, California-based CB Therapeutics, Hurd will focus on creating business partnerships with companies in the psychedelic, cannabinoid and food tech industries. In May, CB Therapeutics won a patent covering the use of microorganisms to produce psychedelic tryptamines and…
CB Therapeutics hires new business development lead
The biosynthesis company CB Therapeutics has named Tiffany Hurd as its new business development lead. At Carlsbad, California-based CB Therapeutics, Hurd will help forge partnerships with organizations that will benefit the company’s sustainability, value propositions and longevity. Hurd has more than 14 years of experience working in senior neurology and neuroscience positions at Fortune 500…